Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Rebillard

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Carcinogenesis|July 11, 2006
DNA-methylation-dependent alterations of claudin-4 expression in human bladder carcinomaStéphanie Boireau, Michael Buchert, Michael S Samuel, et al.
BJU International|February 22, 2011
Correlation of prostate-specific antigen nadir and biochemical failure after high-intensity focused ultrasound of localized prostate cancer based on the Stuttgart failure criteria - analysis from the @-RegistryRoman Ganzer, Cary N Robertson, John F Ward, et al.
Urology|November 16, 2005
Effects of long-term finasteride treatment on prostate cancer morphology and clinical outcomeMark A Rubin, Yves Allory, Vincent Molinié, et al.
Urology|July 26, 2011
Radical prostatectomy for high-risk prostate cancer defined by preoperative criteria: oncologic follow-up in national multicenter study in 813 patients and assessment of easy-to-use prognostic substratificationGuillaume Ploussard, Alexandra Masson-Lecomte, Jean-Baptiste Beauval, et al.
American Journal of Clinical Oncology|April 8, 2006
Subcutaneous interleukin-2 and interferon-alpha in metastatic renal cell carcinoma: results of a French regional experience in LanguedocStéphane Culine, François Iborra, Nicolas Mottet, et al.
The Journal of Urology|July 27, 2014
Prosbiotate: a multicenter, prospective analysis of infectious complications after prostate biopsyFranck Bruyère, Sandra Malavaud, Philippe Bertrand, et al.
BJU International|September 24, 2013
Microarray gene expression profiling and analysis of bladder cancer supports the sub-classification of T1 tumours into T1a and T1b stagesFrançoise Descotes, Philippe Dessen, Pierre Paul Bringuier, et al.
Cancer Treatment Reviews|September 26, 2016
Chemotherapy in hormone-sensitive metastatic prostate cancer: Evidences and uncertainties from the literatureGwenaëlle Gravis, François Audenet, Jacques Irani, et al.
BJU International|April 25, 2009
High-intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failureAndreas Blana, Stephen C W Brown, Christian Chaussy, et al.
Cancer Epidemiology|October 17, 2020
Epidemiology of metastatic castration-resistant prostate cancer: A first estimate of incidence and prevalence using the French nationwide healthcare databaseNicolas H Thurin, Magali Rouyer, Marine Gross-Goupil, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Carcinogenesis|July 11, 2006
DNA-methylation-dependent alterations of claudin-4 expression in human bladder carcinomaStéphanie Boireau, Michael Buchert, Michael S Samuel, et al.
BJU International|February 22, 2011
Correlation of prostate-specific antigen nadir and biochemical failure after high-intensity focused ultrasound of localized prostate cancer based on the Stuttgart failure criteria - analysis from the @-RegistryRoman Ganzer, Cary N Robertson, John F Ward, et al.
Urology|November 16, 2005
Effects of long-term finasteride treatment on prostate cancer morphology and clinical outcomeMark A Rubin, Yves Allory, Vincent Molinié, et al.
Urology|July 26, 2011
Radical prostatectomy for high-risk prostate cancer defined by preoperative criteria: oncologic follow-up in national multicenter study in 813 patients and assessment of easy-to-use prognostic substratificationGuillaume Ploussard, Alexandra Masson-Lecomte, Jean-Baptiste Beauval, et al.
American Journal of Clinical Oncology|April 8, 2006
Subcutaneous interleukin-2 and interferon-alpha in metastatic renal cell carcinoma: results of a French regional experience in LanguedocStéphane Culine, François Iborra, Nicolas Mottet, et al.
The Journal of Urology|July 27, 2014
Prosbiotate: a multicenter, prospective analysis of infectious complications after prostate biopsyFranck Bruyère, Sandra Malavaud, Philippe Bertrand, et al.
BJU International|September 24, 2013
Microarray gene expression profiling and analysis of bladder cancer supports the sub-classification of T1 tumours into T1a and T1b stagesFrançoise Descotes, Philippe Dessen, Pierre Paul Bringuier, et al.
Cancer Treatment Reviews|September 26, 2016
Chemotherapy in hormone-sensitive metastatic prostate cancer: Evidences and uncertainties from the literatureGwenaëlle Gravis, François Audenet, Jacques Irani, et al.
BJU International|April 25, 2009
High-intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failureAndreas Blana, Stephen C W Brown, Christian Chaussy, et al.
Cancer Epidemiology|October 17, 2020
Epidemiology of metastatic castration-resistant prostate cancer: A first estimate of incidence and prevalence using the French nationwide healthcare databaseNicolas H Thurin, Magali Rouyer, Marine Gross-Goupil, et al.
Pageof 7